top of page

What to expect before, during, and after treatment

​​

Timelines vary by patient and center. Below is a typical sequence to help you plan and ask informed questions.
​​

​​Pre-treatment evaluation 

Medical review, lab tests, imaging, and care planning with your treating team. 
​
Phase I: mobilization & collection (~1.5 weeks)
Stem cell mobilization and collection (apheresis) at a qualified center
​
Manufacturing window (~28 days) 
Product is manufactured; travel planning and monitoring as advised by your team. 
​
Phase II: conditioning + infusion + monitoring (6-12 weeks) 
Hospital-based chemotherapy conditioning, infusion, and close monitoring until recovery milestones 
​
Long-term follow-up 
Regular check-ups and laboratory monitoring; long-term follow-up is recommended for gene therapy

​​​

Core Steps
​​

1.

2.

3.

4.

5.

​​​

Care Coordination Support
​​

​​​Our Patient Access team can help coordinate document readiness, translation support, and travel/logistics planning, aligned with your care team's requirements â€‹â€‹

​​​

For international patients
​​

​​​​

Long-term monitoring
​​

​​​Long-term follow-up and periodic blood testing are typically recommended after gene therapy to monitor safety and ongoing effectiveness. We will guide the appropriate schedule. â€‹â€‹

​​​​

A standard part of gene therapy care
​​

This website is not intended to diagnose, treat, cure, or prevent any disease, nor to provide medial advice. Treatment decisions should be made with qualified healthcare professional. Availability and eligibility may vary.

WHATSAPP

Tel: +86 157 1005 1714 (GMT +8)

  • Facebook
  • LinkedIn

WECHAT

ID: keeweet (GMT +8)

Kanexthal, X003 or KL003, is owned by Kanglin Biotec (Hangzhou) Co.,Ltd.(referred to as Kanglin Biotec).

bottom of page